Stay informed

Sign up for the latest information about WAINUA

Fields marked with an * are required.

AstraZeneca is committed to helping healthcare professionals provide appropriate care for their patients. Please provide us with this information so that we can keep your records up to date and can send you any information that you request. If in the future you no longer want to receive health-related materials from AstraZeneca, please call 1-800-236-9933. Please visit www.azprivacynotice.com to review our Privacy Notice.

You may report side effects related to AstraZeneca products .

You may report side effects related to AstraZeneca products.

IMPORTANT SAFETY INFORMATION

WARNINGS AND PRECAUTIONS

Reduced Serum Vitamin A Levels and Recommended Supplementation WAINUA leads to a decrease in serum vitamin A levels. Supplement with recommended daily allowance of vitamin A. Refer patient to an ophthalmologist if ocular symptoms suggestive of vitamin A deficiency occur.

ADVERSE REACTIONS

Most common adverse reactions (≥9% in WAINUA-treated patients) were vitamin A decreased (15%) and vomiting (9%).

INDICATION

WAINUA injection, for subcutaneous use, 45 mg is indicated for the treatment of the polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults.

Please see the full Prescribing Information.

You may report side effects related to AstraZeneca products.

Stay informed

Sign up for the latest information about WAINUA

IMPORTANT SAFETY INFORMATION

IMPORTANT SAFETY INFORMATION +

IMPORTANT SAFETY INFORMATION

IMPORTANT SAFETY INFORMATION

+